Aquestive Therapeutics Inc (NAS:AQST)
$ 3.27 0.18 (5.83%) Market Cap: 297.69 Mil Enterprise Value: 220.59 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 57/100

Q2 2023 Aquestive Therapeutics Inc Earnings Call Transcript

Aug 08, 2023 / 12:00PM GMT
Release Date Price: $1.94 (-5.37%)
Operator

Good morning, and welcome to the Aquestive Therapeutics Second Quarter 2023 Conference Call. (Operator Instructions) As a reminder, this call will be recorded.

I would now like to introduce your host for today's conference call, Bennett Watson of ICR Westwicke, Investor Relations. You may begin.

Bennett Watson

Thank you, operator. Good morning, and welcome to today's call. On today's call, I am joined by Dan Barber, Chief Executive Officer; and Ernie Toth, Chief Financial Officer, who are going to provide an overview of recent business developments and performance for the second quarter 2023 followed by a Q&A session. During the Q&A session, the team will be joined by Dr. Steve Wargacki, Senior Vice President of R&D; Dr. Carl Kraus, Chief Medical Officer; and Ken Marshall, Chief Commercial Officer.

As a reminder, the company's remarks today correspond with the earnings release that was issued after market close yesterday. In addition, a recording of today's call will be made available on Aquestive's website within the Investors section

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot